ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,266.95
-0.74%
US Tech 100
18,178.40
-1.14%
Dow Jones
38,441.54
-1.06%
Brent Oil
83.265
-0.13%
Bitcoin
68,074.88
0.73%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) News

RZLT

Rezolute (RZLT)

Rezolute Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RZLT
DateTimeSourceHeadlineSymbolCompany
05/28/20242:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
05/24/20242:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
05/21/20244:05PMGlobeNewswire Inc.Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)NASDAQ:RZLTRezolute Inc
05/17/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
05/15/20244:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
05/15/20244:05PMGlobeNewswire Inc.Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
04/23/20248:00AMGlobeNewswire Inc.Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual MeetingNASDAQ:RZLTRezolute Inc
03/11/20245:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
03/11/202410:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
03/06/20247:30AMGlobeNewswire Inc.Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)NASDAQ:RZLTRezolute Inc
02/27/20248:47AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/22/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
02/21/202411:55AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
02/13/20245:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RZLTRezolute Inc
02/13/20244:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
02/13/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
02/13/20244:05PMGlobeNewswire Inc.Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
01/29/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
01/25/202412:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
01/25/202412:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
01/25/202412:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
01/25/202412:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
01/24/20248:00AMGlobeNewswire Inc.Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial OfficerNASDAQ:RZLTRezolute Inc
01/23/20248:00AMGlobeNewswire Inc.Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
12/14/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
12/14/20238:00AMGlobeNewswire Inc.Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
12/13/20238:00AMGlobeNewswire Inc.Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)NASDAQ:RZLTRezolute Inc
11/30/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RZLTRezolute Inc
11/22/20235:16PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RZLTRezolute Inc
11/22/20234:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
 Showing the most relevant articles for your search:NASDAQ:RZLT

Your Recent History

USOTC
CBDW
1606 (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
MGON
Megola (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
SAPX
Seven Arts Entertainment (PK)
NASDAQ
HOLO
MicroCloud Hologram
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
CATV
4Cable TV (PK)
USOTC
GRPS
Gold River Productions (PK)
USOTC
ILST
International Star (PK)
USOTC
FSRN
Fisker (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
SPZI
Spooz (PK)
NYSE
AMC
AMC Entertainment
USOTC
KEGS
1812 Brewing (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved